| Zosano Pharma (ZSAN) | |||
|---|---|---|---|
| 1.06 -0.02 (-1.85%) | 01-25 16:00 | ||
| Open: | 1.08 | Pre. Close: | 1.08 |
| High: | 1.0887 | Low: | 1 |
| Volume: | 5,331,368 | Market Cap: | 108M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 1.092 - 1.097 | 1.097 - 1.102 |
| Low: | 0.988 - 0.994 | 0.994 - 0.998 |
| Close: | 1.052 - 1.061 | 1.061 - 1.068 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 1.53 One year: 1.79 |
| Support: | Support1: 0.82 Support2: 0.52 |
| Resistance: | Resistance1: 1.31 Resistance2: 1.53 |
| Pivot: | 0.90  |
| Moving Averages: | MA(5): 1.05 MA(20): 0.82 MA(100): 0.83 MA(250): 0.87 |
| MACD: | MACD(12,26): 0.12 Signal(12,26,9): 0.09 |
| %K %D: | %K(14,3): 68.93 %D(3): 71.62 |
| RSI: | RSI(14): 69.15 |
| 52-Week: | High: 1.96 Low: 0.328 Change(%): -18.5 |
| Average Vol(K): | 3-Month: 693758 10-Days: 1224203 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ZSAN has closed below upper band by 21.2%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Capital Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 102.07 |
| Shares Float (M) | 101.94 |
| % Held by Insiders | 0.36 |
| % Held by Institutions | 15.59 |
| Shares Short (K) | 6850 |
| Shares Short Prior Month (K) | 7850 |
| Stock Financials | |
|---|---|
| EPS | -0.727 |
| Book Value (p.s.) | 0.540 |
| Profit Margin | |
| Operating Margin | |
| Return on Assets (ttm) | -35.8 |
| Return on Equity (ttm) | -104.3 |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | -0.249 |
| Sales Per Share | |
| EBITDA (p.s.) | -0.318 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -32.90 |
| Levered Free Cash Flow (M) | -27.88 |
| Stock Valuation | |
|---|---|
| PE Ratio | -1.46 |
| PEG Ratio | |
| Price to Book value | 1.96 |
| Price to Sales | |
| Price to Cash Flow | -3.29 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
